STZ enters B cells via a glucose transporter (GLUT2) using a variety of intracellular toxic mechanisms such as production of oxygen free radicals that causes degeneration of pancreatic B cells leading to hypoinsulinemia and subsequent hyperglycemia (33). This evidence concerns the gene SLC2A2 and Hyperglycemia.